Use of additives to contrast media to improve imaging in plain film and computed tomography urography

Investigative Radiology

Volumn 38, Issue 1, 2003, Pages 17-26

  Krause, Werner ^a   Schromm, Matthias ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Dog; Iloprost; Image quality; Iopromide; Iotrolan; Nifedipine; Papaverine; Plain film and CT urography; Rabbit; Sodium nitroprusside; Urea

Indexed keywords

ADALAT PRO INFUSIONE; CONTRAST MEDIUM; ILOPROST; IODINE; IOPROMIDE; IOTROLAN; NIFEDIPINE; NITROPRUSSIDE SODIUM; PAPAVERINE; SHL401; UREA;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG CONCENTRATION; DRUG ELIMINATION; FEMALE; IMAGE QUALITY; INJECTION; KIDNEY CLEARANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TIME; UROGRAPHY; X RAY FILM;

EID: 0037233635     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200301000-00003     Document Type: Article

References (32)

1. Morcos SK, Dawson P, Pearson JD, et al. The haemodynamic effects of iodinated water soluble radiographic contrast media: a review. Eur J Radiol 1998;29:31-46.
2. Owen RM, Powers ER. Influence of contrast media on thrombus formation during coronary angioplasty. J Am Coll Cardiol 1991;18:443-450.
3. Hwang MH, Piao ZE, Murdock DK, et al. Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast media. Radiology 1990;174:453-457.
4. Muschick P, Wehrmann D, Schuhmann-Giampieri G, Krause W. Cardiac and hemodynamic tolerability of iodinated contrast media. Invest Radiol 1995;30:745-753.
5. Dawson P, et al. On the nephrotic potential of the iodinated intravascular agents. Adv X-Ray Contrast 1993;1:2-9.
6. Katzberg RW. New and old contrast agents: Physiology and nephrotoxicity. Urol Radiol 1988;10:6-11.
7. Donadio C, Lucchesi A, Tramonti G, et al. Glomerular and tubular effects of contrast media diatrizoate and iopromide. Ren Fail 1996;18:657-666.
8. Berg KL, Jakobson JA. Nephrotoxicity related to x-ray contrast media. Adv X-Ray Contrast 1993;1:10-18.
9. Haberey M. Hemodynamic profile of iloprost in rats, rabbits and cats. In: Gryglewski RJ, Stock G, eds. Prostacyclin and its stable analogue iloprost, Heidelberg 1987.
10. de Gaetano G, et al. Prostaglandins. Thromboxanes and Platelet Function In: Gryglewski RJ, Stock G, eds. Prostacyclin and its stable analogue iloprost, Heidelberg 1987.
11. Manrique RV. Resistance of platelets to prostacyclin In: Gryglewski RJ, Stock G, eds. Prostacyclin and its stable analogue iloprost, Heidelberg 1987.
12. Krause L, et al. Iloprost antagonizes endothelin-induced vasoconstriction in macro- and microcirculation. Eicosanoids 1990;3:135-138.
13. Krause W, Klopp R, et al. Elimination of the diatrizoate-induced effects on the microcirculation by the prostacyclin derivative iloprost. Invest Radiol 1994;29:922-927.
14. Budavari S, et al. Iloprost, Merck Index 1996;12:842.
15. Reynolds JEF. Martindale The Extra Pharmacopeia, London 1996;1005-1014, 943-945, 1738-1739.
16. Osmialowska Z, et al. Effect of nifedipine monotherapy on platelet aggregation in patients with untreated essential hypertension. Eur J Clin Pharmacol 1990;39:403-404.
17. Inoue Y, et al. Indirect portography enhanced by Nicardipine versus Prostaglandin El. Cardiovasc Interv Radiol 1995;18:92-96.
18. Krause W, Schuhmann-Giampieri G, Staks TH, et al. Dose proportionality of iopromide pharmacokinetics and tolerability after iv injection in healthy volunteers. Eur Radiol 1994;46:339-343.
19. Harding JR, Bertazzoli M, Spinazzi A. A randomised double-blind trial of iomeprol and iopromide in intravenious excretory urography. Eur J Radiol 1994;18:Supplement 1:S93-6.
20. Schmiedel E. Evaluation of the contrast density of iomeprol, Zschr. Eur J Radiol 1994;18:Supplement 1:S97-103.
21. Dominik R, Keysser R, Taenzer V. Iopromide dosage and urographic image quality: Is there an optimal dose? Fortschr Geb Röntgenstrahlen 1989;128:111-115.
22. Kennedy C, Rickards D, et al. A double-blind study comparing the efficiency, tolerance and renal effects of iopromide and iopamidol. Br J Radiol 1988;61:288-293.
23. Bakris GL, Lass NA, Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction for dopamine-1 receptors. Kidney Int 1999;56:206-210.
24. Müller, B, Schmidtke M. Wirkungen des stabilen Prostaglandin-analogon Iloprost auf die mikrovaskuläre Permeabilität, in E. Beltz (ed.): Frühveränderungen bei der Atherogenese 1987.
25. Schröder G, Beckmann R, Schillinger E. Studies on vasorelaxant effects and mechanisms of iloprost in isolated preparations, In: Gryglewski RJ, Stock G eds. Prostacyclin and its stable analogue iloprost, Berlin, Heidelberg 1987, 130.
26. Arzilli F, Giovanetti R, Lenzi M. Acute hemodynamic (systemic and renal) and humoral effects of three increasing doses of iloprost in essential hypertensives. Am J Hypertens 1989;2:856-860.
27. Türker RK, Demirel E, and Sevim ZE. Iloprost preserves kidney function against anoxia. Prostaglandins Leukot Essent Fatty Acids 1988;31:45-54.
28. Purdy KE, and Arendshorst WJ. Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC. J Appl Physiol 1999;277(6):F850-F858.
29. Brown SCW, and O'Reilly PH. The Estimate of Glomerular Filtration Rate during Urography. Acceptability of a Nonionic Contrast Medium as a Marker of Renal Function Invest Radiol 1992;27:74-778.
30. Effersöe H, et al. Measurement of Renal Function with lohexol. Invest Radiol 1990;25:778-782.
31. Bauer KM. Ambulante Schnellmethode zur funktionellen Nierendiagnostik mit Urografin. Die Medizinische 1955;27+28:3-8.
32. Roseno, Klin Wochenschr 1929;25:1165-1170.